Reply to “Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?” | Zendy

Dimitrios P. Kontoyiannis | Zendy; Russell E. Lewis | Zendy

Open Access

Reply to “Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?”

Author(s) -

Dimitrios P. Kontoyiannis,

Russell E. Lewis

Publication year - 2014

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.03224-14

Subject(s) - echinocandins , myeloid leukemia , medicine , leukemia , echinocandin , induction therapy , immunology , intensive care medicine , antifungal , amphotericin b , chemotherapy , caspofungin , fluconazole , dermatology

We acknowledge the [letter of Marini and colleagues][1] ([1][2]), in which the authors raise several issues with regard to our epidemiological analysis of invasive fungal infections (IFIs) among patients receiving antifungal prophylaxis during initial remission induction chemotherapy (RIC) for acute

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research